Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

Consensus

  • Home
  • Consensus
New SCCM–ESICM Consensus Defines Refractory Septic Shock
Posted inCritical Care Infectious Diseases news

New SCCM–ESICM Consensus Defines Refractory Septic Shock

Posted by MedXY By MedXY 05/15/2026
A new SCCM–ESICM Delphi consensus standardizes clinical criteria for refractory septic shock, focusing on persistent hypoperfusion, fluid unresponsiveness, high vasopressor needs, and bedside ultrasound when mixed shock is suspected.
Read More
AUC3 2025: Expert Consensus Roadmap for Renal Cell and Urinary Tract Cancer Care
Posted innews Oncology

AUC3 2025: Expert Consensus Roadmap for Renal Cell and Urinary Tract Cancer Care

Posted by MedXY By MedXY 12/19/2025
The 2025 Advanced Urologic Cancer Consensus Conference (AUC3) issues practical, evidence‑informed expert recommendations on diagnosis, perioperative therapy, frontline and later‑line systemic sequencing, and special populations for RCC and urinary tract cancers.
Read More
International Expert Recommendations on Shockwave Therapy in Sports Medicine: A Practical Summary of the 2025 Delphi Consensus
Posted innews Orthopedics

International Expert Recommendations on Shockwave Therapy in Sports Medicine: A Practical Summary of the 2025 Delphi Consensus

Posted by MedXY By MedXY 11/04/2025
An accessible summary of the 2025 international Delphi recommendations on extracorporeal shockwave therapy (ESWT) for sports-related musculoskeletal injuries, highlighting consensus statements, clinical actions, and areas needing research.
Read More
Defining Relapse in Schizophrenia: New International Consensus to Standardize Research and Care
Posted innews Psychiatry

Defining Relapse in Schizophrenia: New International Consensus to Standardize Research and Care

Posted by MedXY By MedXY 10/30/2025
An international expert consensus offers standardized, operational criteria for defining relapse in schizophrenia to reduce study heterogeneity, improve research comparability, and guide clinical reporting.
Read More
ESD 2025 Consensus: Modern Management of Urinary Stones — Practical Recommendations for Clinicians
Posted inUrology

ESD 2025 Consensus: Modern Management of Urinary Stones — Practical Recommendations for Clinicians

Posted by MedXY By MedXY 10/24/2025
The ESD 2025 expert consensus updates diagnosis, prevention and interventional care for urinary stones—prioritizing metabolic evaluation, morpho‑compositional stone analysis, pressure/temperature safety in endourology, suction-enabled RIRS, and individualized selection between PCNL, RIRS and SWL.
Read More
  • A Mobility-Enabled Active Driver for Berlin Heart EXCOR Showed Zero Major Device Malfunctions in High-Risk Pediatric VAD Support
  • Risk-Based Nurse-Managed Personalized Heart Failure Interventions: The ALLEVIATE-HF Trial
  • Arrhythmia Burden and Clinical Responses Under Continuous Monitoring in Heart Failure: Findings from the ALLEVIATE-HF Trial
  • The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes
  • Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prevention prostate cancer public health randomized clinical trial randomized trial risk stratification semaglutide SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in